First Tracks Biotherapeutics Inc

NASDAQ:TRAX

Biotechnology

Healthcare
$44.50 -4.87%

-$0.89 today

Market cap
$1.87B
Beta
0.00
P/E (TTM)
-6.1
EPS (TTM)
-$2.81
52W Low $14.72High $26.80

Volume 0.75M

Average 0.43M

TRAX Operating Margin

Operating income as a percentage of revenue, showing the profitability of core operations.

No reported Operating Margin figures are available to summarize.

Operating Margin history

Percent of revenue · from the income statement

No Operating Margin data reported for this period type.

Operating Margin vs competitors

How TRAX compares with its peers on the latest reported figures

TRAX Competitors Peer median
Operating Margin for TRAX and competitors
Company Period LTM level YoY 3-year change
ANABAnaptysBio, Inc.LTM Mar 202617.6% +107.2 pp+1139.8 pp
ACRSAclaris Therapeutics, Inc.LTM Mar 2026-961.9% -168.3 pp-673.9 pp
ATTOAttovia Therapeutics, Inc.FY2025-4974.7% ——
IMVTImmunovant, Inc.LTM Sep 2026-7488.4% ——
TRAXFirst Tracks Biotherapeutics IncFY2025— ——
MLTXMoonLake ImmunotherapeuticsFY2025— ——
ODTXOdyssey Therapeutics, Inc.—— ——
CLYMClimb Bio, Inc.FY2025— ——
SABSSAB Biotherapeutics, Inc.FY2025— ——
ELDNEledon Pharmaceuticals, Inc.FY2025— ——
IMUXImmunic, Inc.FY2025— ——
Peer median (excluding TRAX) -2968.3%-30.6 pp+233.0 pp

Competitors are the stored peer set for TRAX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue000
Cost of Revenue0152.35M139.61M
Gross Profit0(152.35M)(139.61M)
Gross Margin———
Research & Development97.59M152.35M139.61M
Selling, General & Admin20.87M28.76M39.39M
Operating Expenses118.46M28.76M39.39M
Depreciation & Amortization2.38M2.4M559K
EBITDA(116.09M)(178.7M)(178.45M)
EBITDA Margin———
Operating Income(118.46M)(181.1M)(179.01M)
Operating Margin———
Interest Income12.31M17.38M0
Interest Expense000
Other Income / Expenses12.31M17.4M12.92M
Income Before Tax(106.15M)(163.71M)(166.09M)
Pre-Tax Margin———
Income Tax Expense000
Net Income(106.15M)(163.71M)(166.09M)
Net Margin———
EPS (Basic)(3.05)0.000.00
EPS (Diluted)(3.05)0.000.00
Weighted Avg Shares34.75M00
Weighted Avg Shares (Diluted)34.75M00

First Tracks Biotherapeutics Inc

NASDAQ:TRAX

Intrinsic Alpha fair value

Locked

Current Price

$44.50

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.